Background: The high-risk patient cohort of uncomplicated type B aortic dissections (uTBADs) needs to be clarified. We compared uTBAD patients treated with best medical treatment (BMT), with and without aortic growth, from the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) trial database. Furthermore, we looked for trends in outcome for aortic growth and remodeling after BMT and thoracic endovascular aortic repair (TEVAR) and BMT (TEVARþBMT).
Methods: BMT patients with available baseline and a 1-year follow-up arterial computed tomography scan were identified. True lumen and false lumen diameter was assessed at baseline and at follow-up. Patients with false lumen growth (group I) and without false lumen growth (group II) were compared. Predictors of false lumen and total lumen (aortic) growth were identified. Lastly, BMT outcomes were compared with BMTþTEVAR for false lumen thrombosis and change in false lumen and total aortic diameter in four sections: 0 to 10 cm (A), 10 to 20 cm (B), 20 to 30 cm (C), and 30 to 40 cm (D) from the left subclavian artery.
Results:
The dissection was significantly longer in group I than in group II (43.2 6 4.9 cm vs 30.4 6 8.8 cm; P ¼ .002). The number of vessels originating from the false lumen at baseline was identified as an independent predictor of false lumen growth (odds ratio, 22.1; 95% confidence interval, 1.01-481.5; P ¼ .049). Increasing age was a negative predictor of total aortic diameter growth (odds ratio, 0.902; 95% confidence interval, 0.813-1.00; P ¼ .0502). The proximal sections A and B showed complete thrombosis in 80.6% in the BMTþTEVAR group compared with 9.5% in the BMT group. In these sections, changes from patent to partial or partial to complete thrombosis were observed in 90.3% of the TEVARþBMT group vs 31.0% in the BMT group. In sections C and D, the change in thrombosis was 74.1% for the TEVARþBMT group vs 20.6% for the BMT group. The false lumen diameter increase at section C was larger in the BMT group. Total lumen diameter decreased in sections A and B in the TEVARþBMT group compared with an increase in the BMT group (e4.8 mm vs þ2.9 mm, and e1.5 mm vs þ3.8 mm, respectively). Sections C and D showed minimal and comparable expansion in both treatment groups.
Conclusions:
The new imaging analysis of the ADSORB trial patients identified the number of vessels originating from the false lumen as an independent predictor of false lumen growth in uTBAD patients. Increasing age was a negative predictor of aortic growth. Our analysis may help to identify which uTBAD patients are at higher risk and should receive TEVAR or be monitored closely during follow-up. (J Vasc Surg 2017;65:964-71.) Uncomplicated type B aortic dissections (uTBADs) are commonly managed with best medical treatment (BMT), with acceptable in-hospital mortality ranging between 1% and 10%.
1,2 However, whether this is still the most ideal strategy for these patients is a topic of ongoing debate because 20% to 50% will require invasive management during follow-up as a result of aneurysmal degeneration of the diseased aortic segments or the occurrence of complications. [3] [4] [5] Thoracic endovascular aortic repair (TEVAR) is commonly accepted as the treatment of choice in complicated acute aortic dissections, and open surgical repair is reserved for young patients, those with connective tissue disease, or who are unsuitable for TEVAR. 6 The optimal treatment during the chronic phase remains unclear and can be technically challenging using stent grafts because of a narrow true lumen and thickening of the intimal flap. 6 Therefore, two trials have been conducted to determine whether TEVAR combined with BMT (TEVARþBMT) for uTBAD patients would give benefits over BMT alone. 7, 8 The Investigation of Stent Grafts in Aortic Dissection (INSTEAD) trial failed to show short-term benefits of TEVAR, 8 but long-term outcomes did favor endovascular management compared with BMT alone in survival and remodeling. 9 In addition, the Acute Dissection Stent
Grafting or Best Medical Treatment (ADSORB) trial showed that there were benefits of TEVAR in remodeling at 1-year follow-up. 10 If patients who are at risk of aortic growth and adverse outcome could be identified, these patients could receive TEVAR in the acute or subacute phase, thereby avoiding the technical difficulties and suboptimal results of chronic TEVAR procedures. To better understand which uTBAD patients are at risk of aortic dilatation, we investigated BMT patients from the ADSORB database, with and without aortic growth, to determine clinical and radiologic predictors of aortic dilatation. Furthermore, we looked for trends in outcome for BMT and TEVARþBMT.
METHODS
Protocol and end points of the ADSORB trial. The rationale and methods of the ADSORB trial have been published previously. 7 In summary, between December 2008 and December 2010, 61 acute uTBAD patients were randomized to BMT (n ¼ 31) or TEVARþBMT (n ¼ 30). The randomization was #14 days after onset of symptoms.
Patients with connective tissue disease were excluded. The TEVAR was performed with a Gore TAG device (W. L. Gore & Associates, Flagstaff, Ariz) #48 hours of randomization.
The primary end point analysis was based on intention to treat and separately by protocol. The distinction between DeBakey type IIIA or IIIB dissections was made based on involvement of the superior mesenteric artery, inferior mesenteric artery, any renal artery, or the abdominal aorta. Double-lumen dissections were included but not other acute aortic syndromes.
Requirements of a proximal landing zone had to be at least 2 cm and allow for a placement of at least a 15-cm device, with a maximum oversizing of 10%. The total implanted stent graft length was determined by the treating hospital. Left subclavian artery (LSA) coverage was allowed for an adequate proximal sealing, and revascularization of the LSA was performed when deemed necessary by the treating team. Coverage of the left common carotid artery was not permitted. Blood pressure was targeted to be 120/80 mm Hg and was checked during follow-up.
The imaging follow-up protocol consisted of computed tomography (CT) imaging at 3 months and 1 year of follow-up. The images were analyzed by an independent core laboratory. The outcomes measured included remodeling, maximum diameter of the true and false lumens, and overall transverse aortic diameter. Dissection-related mortality was defined as death #30 days of the initial treatment, before hospital discharge, #30 days of a secondary TEVAR or open surgical repair, or directly caused by the aortic dissection.
The primary end point was defined as freedom from:
d Incomplete or no false lumen thrombosis in any portion of the false lumen parallel to the stent graft, excluding the distal 2 cm, and in the BMT group at any point in the descending thoracic aorta; d Aortic dilatation of 5 mm or the maximum diameter of the descending thoracic aorta (55 mm); d Aortic rupture (descending thoracic or abdominal aorta) with fresh blood outside the adventitia observed on CT imaging.
Present study. In our retrospective imaging analysis study, BMT patients with an available baseline and follow-up scan were identified. Arterial CT scan diameter measurements were performed at baseline and at the latest follow-up for true and false lumens at the level of the LSA and more distal with 5-cm increments up to 40 cm distal of the LSA. The average increase of the false lumen was calculated and used to group the patients according to any false lumen growth (group I, >0.0 mm increase) or no change in false lumen diameter (group II, #0.0 mm increase).
The two groups were compared for demographics, presenting signs and symptoms, medical history, Fig 1) . We aimed to identify independent predictors of false lumen growth. Furthermore, a separate subanalysis was performed based on the mean total lumen increase (2.5 mm). This mean total lumen growth rate was used to determine independent predictors of aortic (total lumen) growth.
Lastly, TEVARþBMT patients from ADSORB who met the same inclusion criteria were analyzed. This cohort was used to compare the rate of false lumen thrombosis, change in false lumen diameter in the nonstent graft sections (C and D in Fig 1) , and total lumen diameter between both groups in sections A to D (Fig 1) .
The imaging data were analyzed using a local workstation with postprocessing software (TeraRecon, San Mateo, Calif). We used an adaption of a recently published measurement protocol. 11 A centerline was drawn through the true lumen, and all diameter measurements were performed in the axial plane perpendicular to the centerline using a region-of-interest method, where all diameters in 360 are calculated. The maximum diameter was used for analysis. Lumen configuration was defined as elliptical or circular (Fig 2) . Celiac axis, superior mesenteric artery, and left and right renal arteries were identified and scored as originating from the true or false lumen. A patent false lumen was defined as only contrast visible, complete thrombosis as only thrombus visible, and partial thrombosis as both contrast and thrombus visible.
Because of the retrospective character of the data and informed consent was acquired for the initial ADSORB study, informed consent and additional Institutional Review Board approval were waived for this present investigation.
Statistics. Continuous data are reported as mean 6 standard deviation and categoric variables as counts with percentages. Univariate analysis was performed for baseline parameters, and P values are reported when possible. Logistic regression analysis was used to identify independent predictors of false lumen and aortic growth. A subset of variables was first checked one-by-one in a logistic regression model. Six prespecified variables were chosen for this check due to clinical interest: gender, age, body mass index, number of vessels originating from the false lumen, number of partial false lumen thrombosis sections, and number of patent false lumen thrombosis sections. Those related to growth in the univariate model with a P value of <0.3 were included for multivariate logistic regression model building. Gender (P ¼.22), age (P ¼ .29), the number of vessels originating from the false lumen (P ¼ .011), the number of partially thrombosed aortic sections (P ¼ .28), and the number of patent aortic sections (P ¼ .017) were all kept for possible inclusion in a multivariate logistic model. Step-wise removal was then performed with these variables. A P value of <.05 was considered significant. Statistical analysis of the data was performed with SAS software (SAS Institute Inc., Cary, NC) or SPSS 22 software (IBM Corp., Armonk, NY).
RESULTS
Demographics, history, medication, and presenting signs and symptoms. The overall age in the BMT cohort (n ¼ 21) was 57.6 6 14.0 years, with 85.7% men. The mean age in group I was 55.3 6 14.0 years vs 62.3 6 9.4 years in group II. The overall percentage of men in the group showing growth was 92.9% compared with 71.4% in those that did not (P ¼ .247). All outcomes are reported in Table I . Furthermore, on the initial baseline CT scan, all visceral vessels in 71.4% of patients without false lumen growth originated from the true lumen, whereas least one vessel originated from the false lumen in 92.9% of those with false lumen growth (Fig 3) . All results are reported in Table II .
Baseline true and false lumen configuration. The configuration of the true and the false lumens demonstrated that in group I there was no difference between the number of circular and elliptical lumens present. In certain evaluated aortic sections, an elliptical configuration was seen more often, whereas most of the patients in group II showed a circular true lumen. The false lumens in group I showed a balanced ratio between a circular and elliptical configuration, whereas most of the false lumens in group II were elliptical ( Supplementary Fig 1, online only) .
False lumen thrombosis. During follow-up, most sections in both groups were partially thrombosed or patent, whereas only a few showed complete false lumen thrombosis. In group I, a patent false lumen was more present during follow-up compared with partial thrombosis, whereas partial thrombosis was more frequent in group II. In group II, the change toward thrombosis was observed between the initial baseline and subsequent follow-up CTs, whereas in group I, most of the assessed segments remained patent over time ( Supplementary Fig 2, online only) .
Independent predictors of growth. After multivariate logistic regression modeling, the number of vessels originating from the false lumen (odds ratio, 22.1; 95% confidence interval, 1.01-481.5; P ¼ .049) was identified as an independent predictor of false lumen growth. The odds ratio estimate was based on a per-unit increase in the number of vessels originating from the false lumen (predicting growth). Although not statistically significant, the number of patent aortic sections tended to be predictive for false lumen growth (odds ratio, 2.76; 95% Table III .
Outcomes of TEVARþBMT. The TEVARþBMT group (n ¼ 16) was an average age of 61.2 6 9.8 years, and 68.8% were men. Mean dissection length was 38.1 67.4 cm, with mean stent graft coverage of 18.4 6 5.1 cm. In the TEVARþBMT group, the proximal sections, A and B (Table III) showed complete thrombosis in 80.6%, whereas this was 9.5% in the BMT group. Sections distal to the stent graft coverage (C and D) demonstrated complete thrombosis in 22.2% vs 5.9% in the BMT cohort. A trend toward complete false lumen thrombosis in the proximal sections (A and B), meaning change from patent to partial or from partial to complete thrombosis was observed in 90.3% in the TEVARþBMT group and in 31.0% in the BMT cohort. In the distal sections (C and D), 74.1% of the TEVARþBMT exhibited partial, or from partial to complete thrombosis vs 20.6% for the BMT group.
Furthermore, the TEVARþBMT group showed a mean change of false lumen diameter in section C of e14.8 6 11.9 mm vs þ0.9 6 8.1 mm in the BMT group. In the most distal section (D), the mean change was e0.06 6 7.1 mm for TEVARþBMT and e1.4 6 7.3 mm for BMT. A difference in total aortic diameter was observed in sections A (þ2.9 vs e4.8 mm) and B (þ3.8 vs e1.5 mm). These differences were less obvious in sections C and D. All results are reported in Table IV .
DISCUSSION
The number of vessels originating from the false lumen resulted as a predictor of false lumen growth. An increasing number of patent false lumen segments showed a trend of increased false lumen growth, whereas older age showed a trend of increased total aortic growth. These could be indicative of a possible relationship and warrant further study in a larger sample size. The patients who exhibited false lumen growth tended to be younger and had more often a longer segment of dissected aorta.
Side branch involvement was predictive of no false lumen thrombosis. 12 The relationship of side branch involvement and false lumen growth seems logical. Recall, to be considered uTBAD, patients do not show any signs of malperfusion, which means that if the visceral vessels originate from the false lumen, sufficient flow perfused vital organs and limbs. Therefore, the false lumen must be patent or only partially thrombosed (Fig 3) . Yet, this also means a significant amount of blood is being redirected into the false lumen, pressurizing and contributing to an increased aortic growth rate. The role of age, as observed in this present study, with an increased chance of aortic growth in younger patients, has been presented before, 13, 14 whereas increased age has been shown to be associated with decreased aortic growth. 14 The hypothesis is that older patients have less risk to have an inherent misdiagnosed connective tissue disorder that can be associated with a more flexible aortic wall, accounting for the higher risk to develop aortic enlargement.
14-17 The extensiveness of the dissection was significantly greater in the group that showed aortic growth. Patients with a type IIIb dissection could benefit more from an early TEVAR than those with a type IIIa dissection. However, not only the extent of the dissection plays a role in aortic growth, but also many factors, such as entry tear size, number of entry tears, and the presence of re-entry tears, contribute to growth of the false lumen. 18, 19 A patent false lumen was borderline significant as an independent predictor of false lumen growth in our uTBAD cohort. Although statistically borderline, because the sample size was relatively small, this outcome is relevant. The role of the false lumen status remains a highly debated topic. Partial false lumen thrombosis proved to be most predictive for aortic growth in several studies [20] [21] [22] and has even been named as an independent risk factor for aortic growth. 23, 24 Moreover, patients with partial false lumen thrombosis tended to have a larger aortic diameter at presentation compared with other dissection patients. 22 In addition, multiple studies have identified a patent false lumen as a predictor of aortic growth for type B aortic dissections. 13, 15, 17, 18, 23, [25] [26] [27] [28] [29] This finding can be attributed to the hemodynamic stress on the aortic wall with aneurysm formation of weakened aortic segments. In contrast, complete false lumen thrombosis showed a decreased aortic size over time as a result of aortic wall remodeling. 17,25-28 Such a segmented method of assessing the false lumen, not described before, proved useful for detecting thrombosis of the false lumen and changes in aortic diameter at different aortic levels. In particular, it might be an appropriate way to assess the false lumen for thrombosis status instead of regarding the false lumen as a single entity. This is because single aortic sections may behave differently during follow-up (ie, distal sections that were more often patent compared with proximal sections in our analysis). Furthermore, it is important to consider false lumen thrombosis as a time-dependent parameter instead of a snapshot characteristic. Although some sections may be partially thrombosed, this does not necessarily mean this is an adverse outcome because this section may be progressing from being patent to becoming completely thrombosed. We observed this mostly in group II, where many segments progressed from patent to partial or even from partial to complete thrombosis. When the results of BMT and TEVARþBMT are compared, a benefit of TEVARþBMT can be observed in remodeling. The rates of complete thrombosis were improved in the TEVARþBMT group. This was previously statistically tested in another ADSORB publication. 10 In general, the results of TEVARþBMT were excellent in remodeling in addition to the absence of aortic-related deaths or major adverse events during the follow-up period. 10 TEVARþBMT did not show the same clear benefit in aortic growth in the most distal descending unstented section, because BMT and TEVARþBMT both showed a small decrease of the false lumen diameter. This may suggest weighing benefits of longer TEVAR treatment lengths with possible complications. This study has several limitations. General limitations of the ADSORB trial include that most ADSORB centers are tertiary referral hospitals, so a selection bias could be present. One of the limitations was varying scan quality and slice thickness that sometimes hindered assessment of radiologic parameters. Furthermore, 10 patients did not meet the inclusion criteria and were excluded. Lastly, the sample size was small, making translation of the results to the general population challenging, although previous experiences have reported similar limited numbers. 30 
CONCLUSIONS
This analysis of the BMT patients from the ADSORB database identified the number of vessels originating from the false lumen as one independent predictor of false lumen growth in uTBAD patients. The number of patent aortic segments was borderline significant as an independent predictor of false lumen growth. Furthermore, increasing age seemed associated with aortic growth, but this finding warrants further study. All of these factors could help to classify which uTBAD patients a Continuous data are reported as mean 6 standard deviation and categoric data as %.
